)
Overview
<ul>
<li>U.S. cannabis operator’s Q4 revenue rose 318% yr/yr, driven by recent M&amp;A deals</li>
<li>Company announced pending acquisitions of Eaze, Schwazze, PharmaCann assets, and MOU for Hawthorne</li>
<li>Q4 adjusted EBITDA grew 347% yr/yr as company realized synergies from recent integrations</li>
</ul>
Outlook
<ul>
<li>Vireo Growth expects pending acquisitions to close in first half of 2026</li>
</ul>
Result Drivers
<ul>
<li>M&amp;A ACTIVITY - Q4 revenue surge attributed to recently closed mergers and acquisitions expanding retail and wholesale footprint</li>
<li>SAME STORE SALES - Pro forma same store sales increased 22% yr/yr</li>
<li>SYNERGIES FROM INTEGRATION - Company realized corporate overhead synergies following integration of Deep Roots, Proper, and Wholesome acquisitions Company press release:</li>
</ul>
Key Details
Metric Beat/Mis Actual Consensu
s s
Estimate
<h3>Q4 $104.50</h3>
Revenue mln
Q4 Gross $56.90
Profit mln For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact . (This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

CBIH

Cannabis company Vireo Growth's Q4 revenue surges on M&A deals